Orbimed

Passage Bio Plans IPO as Three Gene Therapies Approach the Clinic

Passage Bio Plans IPO as Three Gene Therapies Approach the Clinic

20 days ago   |   Xconomy

A year ago Passage Bio launched with $115.5 million and plans to advance a handful of gene therapies discovered at the University of Pennsylvania. Now the Philadelphia-based...
Read more ...

Arcutis Bio Raises $159M in Upsized IPO to Test Skin Disease Drugs

Arcutis Bio Raises $159M in Upsized IPO to Test Skin Disease Drugs

23 days ago   |   Xconomy

Arcutis Biotherapeutics raised about $159 million from its IPO, offering 1.6 million more shares than anticipated and pricing at the high end of its planned range. The Westlake...
Read more ...

Takeda Pays Turnstone $120M to Start Alliance on Viral Cancer Therapies

Takeda Pays Turnstone $120M to Start Alliance on Viral Cancer Therapies

2 monthes ago   |   Xconomy

Turnstone Biologics has yet to test its engineered viruses in cancer patients but Takeda Pharmaceutical sees enough promise in the technology to pay $120 million upfront to...
Read more ...

Aspen Neuro Bags $6.5M to Test Parkinson's Disease Stem Cell Therapy

Aspen Neuro Bags $6.5M to Test Parkinson's Disease Stem Cell Therapy

2 monthes ago   |   Xconomy

Nearly nine years ago Jeanne Loring and her colleagues at Scripps Research debuted a test that leveraged advances in genomics and data science to determine, without testing in...
Read more ...

Astellas Bets On Gene Therapy With $3B Audentes Acquisition Offer

Astellas Bets On Gene Therapy With $3B Audentes Acquisition Offer

2 monthes ago   |   Xconomy   |   2 articles

Japanese drug giant Astellas Pharma announced late Monday it has agreed to buy Audentes Therapeutics, which is developing gene therapies for rare neuromuscular diseases. It's...
Read more ...

Pfizer Spinout SpringWorks, Migraine Drug Firm Satsuma Prep IPOs

Pfizer Spinout SpringWorks, Migraine Drug Firm Satsuma Prep IPOs

6 monthes ago   |   Xconomy

The dog days of summer are here and IPO activity has slowed, but that hasn't stopped some biotech companies from securing a place in the line leading to Wall Street. Late...
Read more ...

Acutus, Maker of Next-Gen Electrophysiology Tech, Adds $100M Series D

Acutus, Maker of Next-Gen Electrophysiology Tech, Adds $100M Series D

7 monthes ago   |   Xconomy   |   2 articles

A company that makes a mapping system to help doctors see high-resolution, 3D images of irregular heart rhythms in real time has raised $100 million in venture investment and a...
Read more ...

Turning Point Prices IPO, Raising $166M to Test Cancer Drugs

Turning Point Prices IPO, Raising $166M to Test Cancer Drugs

10 monthes ago   |   Xconomy   |   3 articles

Turning Point Therapeutics raised more than $166 million in its IPO, pricing at the top of its range and putting nearly 2 million more shares into the public markets than it...
Read more ...

SpringWorks, Armed With Ex-Pfizer Cancer Drugs, Reloads With $125M

SpringWorks, Armed With Ex-Pfizer Cancer Drugs, Reloads With $125M

10 monthes ago   |   Xconomy

SpringWorks Therapeutics, a startup spun out of Pfizer to develop drugs gathering dust on the New York pharma giant's shelves, has closed its second nine-figure financing round...
Read more ...

Turning Point Therapeutics Plans IPO to Advance Targeted Cancer Drugs

Turning Point Therapeutics Plans IPO to Advance Targeted Cancer Drugs

11 monthes ago   |   Xconomy   |   2 articles

Turning Point Therapeutics, which is developing targeted cancer drugs for patients whose tumors resist other precision therapies, has outlined plans for an IPO. The company...
Read more ...


Register you to post on BioTech Mag

Free Registration

World Biotechnology Congress 2019

Hilaris Conferences is going to host its premier World Biotechnology Congress 2019 during October 01-02, 2019, Valencia, Spain. Biotechnology 2019 Congress aim to create a... Read more ...

World Biotechnology Congress 2019

Hilaris Conferences is going to host its premier World Biotechnology Congress 2019 during October 01-02, 2019, Valencia, Spain. Biotechnology 2019 Congress aim to create a... Read more ...

2nd International Conference on Tissue Science and Regenerative Medicine

This conference is designed for experts in academia and industries working in the tissue science and regenerative field, this conference will examine cutting-edge research in... Read more ...

Invetx Fetches $15M to Develop Biologic Drugs for Man's Best Friend

Invetx Fetches $15M to Develop Biologic Drugs for Man's Best Friend

Veterinarians have a saying that a cat is not a small dog, says Invetx CEO Juergen Horn. Obviously, a dog of any size isn't the same as a human. But Horn, a veterinarian, says... Read more ...

Lundbeck's Alder Bio Bet Pays Off With FDA Approval of Migraine Drug

Lundbeck's Alder Bio Bet Pays Off With FDA Approval of Migraine Drug

A migraine drug that Lundbeck added to its pipeline via its nearly $2 billion acquisition of Alder BioPharmaceuticals won FDA approval on Friday. The drug, eptinezumab , is... Read more ...

Arima Genomics Completes Series A Financing

SAN DIEGO--Arima Genomics, Inc., a company focused on research tools to accelerate the understanding of genome sequence and structure toward their role in human health and... Read more ...

Viking Therapeutics to Participate in Upcoming Investor Conferences

SAN DIEGO, Feb. 24, 2020 /PRNewswire/ - Viking Therapeutics, Inc. , a clinical-stage biopharmaceutical company focused on the development of novel therapies for metabolic and... Read more ...

Molecular characterization and overexpression analyses of secologanin...

Abstract Camptothecin is a high-value anti-cancerous compound produced in many taxonomically unrelated species. Its biosynthesis involves a complex network of pathways and a... Read more ...

Modulation of the Purine Pathway for Riboflavin Production in Flavinogenic...

Riboflavin is an indispensable nutrient for humans and animals, since it is the precursor of the essential coenzymes FMN and FAD, involved in variety of metabolic reactions... Read more ...

A Critical Review of Genome Editing and Synthetic Biology Applications in...

Being the green gold of the future, microalgae and cyanobacteria have recently attracted considerable interest worldwide, for they can be used to produce different kinds of... Read more ...

Biodegradation of penicillin G from industrial bacteria residue by...

An efficient biodegradation-strengthening approach was developed to improve penicillin G degradation from industrial bacterial residue in an expanded bed adsorption bioreactor... Read more ...

More clues for how the monkeyflower got its spots

The monkeyflower, or Mimulus, though possessing a relatively simple genome is able to produce a stunning array of pigmentation patterns. A team of researchers is one step... Read more ...

A deep dive into cellular aging

Scientists have discovered that mitochondria trigger senescence, the sleep-like state of aged cells, through communication with the cell's nucleus -a nd identified an... Read more ...